Today after the close the following companies were scheduled to report earnings: APOL, PSMT, WDFC, CUDA, HELE.
Futures are mixed after hours: S&P 500 futures are +0.75 from fair value of 2,091 and Nasdaq100 futures are -0.50 from fair value of 4,452.
Tomorrow morning before the open, economic reports scheduled to be released include: Nonfarm Payrolls (Consensus 175K), Nonfarm Private Payrolls (Consensus 170K), Unemployment Rate (Consensus 4.8%), Hourly Earnings (Consensus 0.2%), Average Workweek (Consensus 34.4).
Tomorrow before the open the following companies are scheduled to report earnings: None.
In corporate news, Eleven Biotherapeutics (EBIO) announced that the company's Investigational New Drug (IND) application for EBI-031, a humanized monoclonal antibody that potently binds interleukin-6 (IL-6) and inhibits all known forms of IL-6 cytokine signaling, for treatment of ocular diseases, has become effective. As a result of the achievement of this milestone, Eleven is entitled to receive a $22.5 million payment from F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (Roche) pursuant to the terms of its license agreement with Roche.
Following this news, shares of EBIO rallied and are now up 25% at $2.45/share.